Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MIF | P14174 | 3/20 | 0.53 |
| ▸ | CA1 | P00915 | 3/20 | 0.52 |
| ▸ | CA2 | P00918 | 3/20 | 0.52 |
| ▸ | CA7 | P43166 | 2/20 | 0.52 |
| ▸ | CA9 | Q16790 | 2/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.52 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.52 |
| ▸ | NOS3 | P29474 | 2/20 | 0.48 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.48 |
| ▸ | HTR3B | O95264 | 1/20 | 0.48 |
| ▸ | HTR3A | P46098 | 1/20 | 0.48 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.48 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.43 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5120033 | 0.94 | MIF (0.48) | MIFCA1CA2CA7CA9 | |
| SCHEMBL91815 | 0.90 | APP (0.55) | MIFCA1CA2CA7CA9 | |
| SCHEMBL9380858 | 0.84 | HTR3E (0.53) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL1417852 | 0.83 | CA1 (0.55) | MIFCA1CA2CA7CA9 | |
| Bitoscanate SCHEMBL157128 | 0.82 | MIF (0.72) | MIFCA1CA2CA9P2RY6 | |
| SCHEMBL7620598 | 0.81 | CA1 (0.52) | MIFCA1CA2CA7CA9 | |
| SCHEMBL941550 | 0.80 | MIF (0.56) | MIFCA1CA2P2RY6TSHR | |
| SCHEMBL161063 | 0.79 | CYP3A4 (0.50) | CA1CA2CA7CA9CA12 | |
| SCHEMBL12198411 | 0.79 | CA1 (0.50) | MIFCA1CA2CA7CA9 | |
| SCHEMBL1021008 | 0.79 | ALDH1A1 (0.50) | MIFCA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 899 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12402638-B2 | Materials and methods for extending shelf-life of foods | JP LABORATORIES, INC. (US) | 2025-09-02 | — | — | US | claimed |
| US-20250194617-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-06-19 | — | — | US | claimed |
| CN-116947780-B | Preparation method of thiazolidine-4-thioketone derivative | 华侨大学 | 2025-06-03 | — | — | CN | claimed |
| US-20250169514-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-05-29 | — | — | US | claimed |
| US-20250084759-A1 | FLUORESCENT DYE OIL TRACER COMPOSITIONS | SAUDI ARABIAN OIL COMPANY (SA) | 2025-03-13 | — | — | US | claimed |
| US-12232516-B2 | Materials and methods for extending shelf-life of foods | JP LABORATORIES, INC. (US) | 2025-02-25 | — | — | US | claimed |
| US-12193465-B2 | Materials and methods for extending shelf-life of foods | JP LABORATORIES, INC. (US) | 2025-01-14 | — | — | US | claimed |
| CN-119080660-A | Thiosemicarbazide menthyl formate compound, preparation method and application thereof | 南京林业大学 | 2024-12-06 | — | — | CN | claimed |
| CN-117843276-B | Multi-component composite steel slag grinding-aid excitant and preparation method thereof | 华新水泥股份有限公司 | 2024-11-26 | — | — | CN | claimed |
| WO-2024177606-A1 | QUINAZOLINONE DERIVATIVE COMPOUNDS SHOWING ANTI-CANCER ACTIVITY AND THE SYNTHESIS METHODS OF THESE COMPOUNDS | BILECIK SEYH EDEBALI UNIVERSITESI (TR) | 2024-08-29 | — | — | WO | claimed |
| CN-106188079-A | 7 piperazine thioureas of camptothecine, preparation method and purposes | 兰州大学 | 2016-12-07 | — | — | CN | claimed |
| CN-106045938-A | Synthesis method of dehydroabietic-acid-based B ring-fused-thiazole-thiocarbamide compounds | 广西大学 | 2016-10-26 | — | — | CN | claimed |
| US-20160250175-A1 | COMBINED APPLICATION OF ISOTHIOCYANATE COMPOUND AND ANTI-CANCER MEDICINE | JC (WUXI) COMPANY, INC. (CN) | 2016-09-01 | — | — | US | claimed |
| EP-3034076-A1 | COMBINED APPLICATION OF ISOTHIOCYANATE COMPOUND AND ANTI-CANCER MEDICINE | JC (Wuxi) COMPANY, Inc. (CN) | 2016-06-22 | — | — | EP | claimed |
| CN-103864655-B | A kind of synthetic method of dehydrogenation abietyl thiourea derivative | GUANGXI UNIVERSITY (CN) | 2015-12-30 | — | — | CN | claimed |
| US-8940434-B2 | Electrolyte additive and electrolyte and lithium rechargeable battery including same | SAMSUNG SDI CO., LTD. (KR) | 2015-01-27 | — | — | US | claimed |
| CN-102924383-B | 2-sulfohydantoin as well as preparation method and application thereof | UNIV SOUTHERN MEDICAL | 2014-11-05 | — | — | CN | claimed |
| CN-104117064-A | Combined application of isothiocyanate compound and hormone medicine | WUXI JC PHARMACAUTICAL TECHNOLOGY INC | 2014-10-29 | — | — | CN | claimed |
| CN-103864655-A | Synthetic method of dehydroabietic acid group thiourea derivative | UNIV GUANGXI | 2014-06-18 | — | — | CN | claimed |
| US-20140134480-A1 | ELECTROLYTE ADDITIVE AND ELECTROLYTE AND LITHIUM RECHARGEABLE BATTERY INCLUDING SAME | SAMSUNG SDI CO., LTD. (KR) | 2014-05-15 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160250175-A1 | COMBINED APPLICATION OF ISOTHIOCYANATE COMPOUND AND ANTI-CANCER MEDICINE | CHUK, KIT, MKI67 | MIF 986/4885CA1 1745/4885CA2 924/4885 |
| US-20140134480-A1 | ELECTROLYTE ADDITIVE AND ELECTROLYTE AND LITHIUM RECHARGEABLE BATTERY INCLUDING SAME | TST, SLC26A3, CLCN2 | MIF 3547/4885CA1 391/4885CA2 319/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.